01 1Sichuan Xieli Pharmaceutical
01 1IRINOTECAN HCL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-12-21
Pay. Date : 2018-11-16
DMF Number : 21713
Submission : 2008-06-10
Status : Active
Type : II
20
Sichuan Xieli Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IRINOTECAN HCL, with a corresponding US DMF Number 21713.
Remarkably, this DMF maintains an Active status since its submission on June 10, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 21, 2018, and payment made on November 16, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
